Table 1 Baseline characteristics of patients with active and inactive SLE
Variables | Active SLE (n = 64) | Inactive SLE (n = 54) | p value |
|---|---|---|---|
Demographic data | |||
Age, years | 33.5 (19.0) | 41.5 (20.0) | 0.029 |
Female sex, n (%) | 57 (89.0) | 42 (77.7) | 0.098 |
Disease duration, (months) | 1.0 (75.5) | 62.5 (177.0) | <0.001 |
SLEDAI-2 K | 8.0 (5.0) | 2.0 (2.0) | <0.001 |
New-onset SLE, n (%) | 33 (51.5) | 5 (9.2) | <0.001 |
Laboratory data | |||
WBC count (/μL) | 3570.0 (3225.0) | 4900.0 (3450.0) | 0.006 |
Haemoglobin (g/dL) | 9.9 (2.5) | 13.2 (2.4) | <0.001 |
Platelet count (×1000/μL) | 158.5 (125.0) | 227.0 (111.0) | <0.001 |
Lymphocyte count (/μL) | 580.0 (461.0) | 1260.0 (770.0) | <0.001 |
ESR (mm/h) | 46.5 (55.0) | 19.5 (23.0) | <0.001 |
CRP (mg/L) | 9.9 (20.3) | 0.6 (1.5) | <0.001 |
BUN (mg/dL) | 13.7 (9.9) | 12.8 (5.3) | 0.025 |
Cr (mg/dL) | 0.6 (0.4) | 0.6 (0.2) | 0.047 |
Albumin (mg/dL) | 2.9 (1.0) | 4.1 (0.5) | <0.001 |
AST (IU/L) | 30.5 (27.5) | 19.5 (7.0) | 0.028 |
ALT (IU/L) | 18.5 (15.5) | 16.5 (13.0) | 0.036 |
Total bilirubin (mg/dL) | 0.4 (0.2) | 0.5 (0.3) | 0.726 |
Complement 3, mg/dL | 50.4 (41.0) | 85.0 (33.6) | <0.001 |
Complement 4, mg/dL | 8.5 (9.4) | 16.4 (9.3) | <0.001 |
Anti-dsDNA (IU/mL) | 163.5 (360.0) | 0.0 (43.0) | <0.001 |
Urine P/Cr ratio | 0.4 (2.8) | 0.0 (0.1) | <0.001 |